Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, announced it has acquired Semprus BioSciences (Cambridge, Massachusetts), a biomedical company and spin out from Massachusetts Institute of Technology (MIT). The acquisition includes the core Semprus Sustain(TM) Technology. The transaction brings to Teleflex an innovative and patented platform technology that serves as the basis for next-generation medical devices. The technology is designed to provide the benefits of reducing complications such as thrombosis and microbial adhesion over long durations.
ReCor Medical has reported six-month follow-up data on eight patients who have been treated via renal denervation for their resistant hypertension with the company s Paradise system. According to a company release, this is the only system for renal denervation that is based on ultrasound, not radiofrequency, energy.
Siemens Healthcare (NYSE: SI) has announced that the SOMATOM Definition Edge single-source computed tomography (CT) system – the first single-source CT to use Siemens recently introduced Stellar Detector – has been approved for sale in the United States. With ever-greater patient volumes in the Emergency Department (ED) setting, where 40 percent(1) of CT examinations are performed, hospital demand is increasing for more efficient and cost-effective imaging solutions. With these escalating ED needs in mind, Siemens designed the SOMATOM Definition Edge CT system, which demonstrates Siemens innovation and competitiveness – goals of the Healthcare Sector s Agenda 2013 two-year global initiative.
There are plenty of parallels in the history of medical device development, but there’s no doubting the fact that this particular bandwagon is gathering pace at a rate not seen since the early days of coronary angioplasy, balloons, stents and all that. And it’s easy to see why, because renal denervation, despite being a recently developed therapy, does seem to be generating a fistful of good results, demonstrating immediate and sustained blood pressure reduction in patient hitherto resistant to pretty much any other form of anti-hypertensive therapy.
In the Hot Topics Debate session at the Society of Interventional Radiology’s annual scientific meeting in San Francisco, USA, co-ordinated by Daniel Sze, William T Kuo and John F Angle spoke for the motion “catheter-based lysis is superior to intravenous lysis and surgery for massive and submassive pulmonary embolism”. They took on the Scott O Trerotola and Suresh Vedantham who spoke against the motion and argued that there were no data to support catheter interventions for pulmonary embolism.
Renal Denervation is one of the hottest topics in medical devices at the moment and German outfit ReCor Medical has been in the fray with its announcement of CE marking for its Paradise™ system earlier this year (details here). Now the company has reported six-month follow-up data on eight patients who have been treated via renal denervation for their resistant hypertension with the company s unique ultrasound-based system.
A filter used to block clots from passing from the veins in the legs to the arteries of the lung does not improve mortality rates for most patients suffering a pulmonary embolism. However, if a patient is unstable - in shock or requires a ventilator - filters can save lives.
Medtronic has announced the start of SYMPLICITY HTN-3, the company’s US clinical trial of the Symplicity renal denervation system for treatment-resistant hypertension. The first patient in this landmark study was enrolled at the Prairie Heart Institute at St John’s Hospital in Springfield, USA.
BTG has expanded its commercial presence in Europe in recent months by building an expert sales force to promote the approved uses of its products in major European markets. This team has been selling BTG’s radioembolization product TheraSphere and will also sell DC Bead and Bead Block, the company’s complementary interventional oncology products.
A strong message on retaining quality but reducing cost came from Robert Kerlan, professor of Clinical Radiology and Surgery, University of California San Francisco, USA, who delivered the Dotter Lecture at SIR s annual scientific meeting in Atlanta, USA.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos